AdvaMed And Ortho Firms Look To Chinese Market As Alternative To Japan’s
This article was originally published in The Gray Sheet
Executive Summary
As frustrations mount with Japan's device regulatory and reimbursement agencies, manufacturers who are looking to gain a foothold in the growing Asian market could transfer resources to China, AdvaMed CEO Steve Ubl said
You may also be interested in...
BSD Medical Plans To File PMA For Cancer Therapy, Prepares Japanese Strategy
BSD Medical plans to submit a PMA application by the end of the quarter for its non-invasive BSD-2000 tumor hyperthermia therapy system to treat cancer
BSD Medical Plans To File PMA For Cancer Therapy, Prepares Japanese Strategy
BSD Medical plans to submit a PMA application by the end of the quarter for its non-invasive BSD-2000 tumor hyperthermia therapy system to treat cancer
Chilly Japanese Medical Device Climate Draws Fire From Hill, Industry
Japan's regulatory and reimbursement systems came under fire this week from lawmakers on Capitol Hill and attendees of AdvaMed's international conference in Arlington, Va